Scientists at a Melbourne research institute in Australia have found that a medicine used to treat blood cancer can kill HIV cells. Know in...

Experts meets pharma execs seeking enough stock of Lopinavir and Ritonavir to be kept ready for India.

Cipla, the sole producer of lopinavir/ritonavir, a combination HIV drug prescribed for paediatric patients, has stopped manufacturing it ov...

Only one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market, because of a licensing agreement wit...

Up to 45 per cent of HIV-infected mothers will transmit the virus to their child, usually through breastfeeding, researchers said.

The UN General Assembly adopted a new political declaration that emphasised on the critical importance of affordable medicines to combat th...

The stigma of HIV remains. But with modern medicines, Charlie Sheen and others infected by the virus can lead a normal life.

India has been able to achieve a more than 20% decline in new HIV infections between 2000 and 2014, according to a UN report.

Under the project PrEP, regular medicine would be given to an HIV-negative sex worker engaged in sex with an HIV-positive person.

Aurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...

Shilpa Medicare inked an agreement with Gilead Sciences to increase access to medicines used for treatment of HIV/AIDS.

Strides has inked a pact with Gilead Sciences Inc to sell low-cost generic versions of latter's HIV medicine 'emtricitabine' in developing ...

Gilead Sciences has signed deals with 3 Indian firms to collaborate on promoting access to HIV medicine emtricitabine in developing nations.

Hyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...

Patient advocacy and civil society groups working in the area of HIV/AIDS have criticized free trade agreements (FTAs) being signed between...

India has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...

Besides I-MAK, a few local HIV drug makers such as Cipla and US-based Mylan-owned Matrix Laboratories had also opposed Abbott's attempt to ...